Current Registered participants to date ( 148 ) Jul 19, 2018
857 people have visited this website.


Alessio Ciulli
University Chemical Laboratory, University of Cambridge, UK.

Alessio Ciulli graduated Magna Cum Laude in Chemistry at the University of Florence in Italy, studying under Prof. Ivano Bertini at the Magnetic Resonance Centre. In 2002 he joined the laboratory of Prof. Chris Abell at the University of Cambridge in UK to study for a PhD in Chemical Biology, funded by a Gates Cambridge Scholarship and a BBSRC CASE Award in collaboration with Astex Therapeutics. After receiving his PhD in 2006, Dr. Ciulli was elected to a Junior Research Fellowship at Homerton College to carry out postdoctoral research at Cambridge, with Prof. Abell and Prof. Tom Blundell. He was recently awarded a Human Frontier Science Program Fellowship at Yale University in the United States to work with Prof. Craig Crews. His research interests are on biophysical and structural methods in protein-ligand and protein-protein molecular recognition, and on fragment-based approaches for drug design and chemical biology.

Emanuele Paci
Faculty of Biological Sciences and School of Physics and Astronomy, University of Leeds, UK.

Emanuele Paci studied Physics in Rome and obtained a PhD in Chemistry from the University of Paris 6 in 1996. He did postdocs with Martin Karplus in Strasbourg and Chris Dobson in Oxford. In 2001 he moved on becoming group leader at the Biochemistry Institute of the University of Zurich. Since 2004 he is University Research Fellow at the University of Leeds.

Richard Smith
Protein Therapeutics Laboratory, King's College London, and Department of Clinical Medicine, University of Cambridge, UK.

Richard Smith is director of the Protein Therapeutics Laboratory at King’s College London – the laboratory is located within Guy’s Hospital and is part of a recently established Centre for Transplantation funded by the UK Medical Research Council. He is also an honorary senior Fellow in the Department of Clinical Medicine at Cambridge University. Richard is a specialist in improving the therapeutic performance of enzymes and other protein drugs by manipulating their molecular interactions in vivo. This approach uses genetically based protein engineering and post-translational modifications to confer new effector functions on known biological agents. Richard studied chemistry and biochemistry at Oxford University and he gained extensive experience of drug development and translational research over 33 years in the pharmaceutical and biotechnology industries. This included playing a major role in the invention and development of the marketed acyl-enzyme thrombolytic prodrug Anistreplase and the progression of three other agents from bench to bedside. He co-founded a biotechnology company (Adprotech Ltd) in Cambridge (UK) and this company was responsible for advancing one of these agents to the clinic and for the discovery and early-stage development of several others. He has published approximately 100 scientific papers in fields ranging from protein structure and function to cardiovascular pharmacology and molecular immunology.

Garry Taylor
Centre for Biomolecular Sciences, University of St Andrews, UK.

Graduated in Physics in London, and then PhD at Kings College London under Professor Maurice Wilkins FRS and Stephen Neidle focusing on the crystallography of anti-cancer drugs that interact with DNA. 1928-1982: postdoctoral position at Birkbeck College, London under Sir Tom Blundell FRS working on aspartate proteases. 1982-1989: postdoctoral position under Sir David Phillips FRS, focusing on computational crystallography and structures of monoclonal antibodies. 1989-1999: Lecturer to Professor at the University of Bath, where I helped establish a protein crystallography unit and focused on sialidases and the structural basis of thermostability. 1999-present, Professor Molecular Biophysics and Director of the Centre for Biomolecular Sciences at the University of St Andrews.

Malcom Walkinshaw
Institute of Structural and Molecular Biology, University of Edinburgh, UK.

Malcolm Walkinshaw obtained both his BSc (1973) and PhD (1976) degrees from the Chemistry Department at the University of Edinburgh. After leading a structure-based drug design group in Sandoz in Switzerland for ten years, he took up the Chair of Structural Biochemistry in 1995 at the University of Edinburgh. He has published over 200 papers on molecular recognition, protein structure and drug discovery. His lab currently consists of 20 research fellows, PhD students and support staff using crystallographic, biophysical and computational approaches to study protein-ligand interactions. He is now director of the newly established Centre for Translational and Chemical Biology.

Paul Williams
School of Molecular Medical Sciences, Centre for Biomolecular Sciences, University of Nottingham, UK.

Paul Williams is currently Professor of Molecular Microbiology and Head, School of Molecular Medical Sciences, University of Nottingham. After graduating in Pharmacy (B.Pharm (Hons), Nottingham) in 1979, he completed his professional MRPharmS training prior to undertaking a Ph.D in microbiology (University of Aston). In 1985 he took up a position as Lecturer in Pharmaceutical Biochemistry in the Department of Pharmaceutical Sciences, University of Nottingham, was promoted to Reader in 1992 and to the Chair of Molecular Microbiology (December 1995). In 1996 he was appointed to the Directorship of the Institute of Infections & Immunity (renamed the Institute of Infection, Immunity and Inflammation in 2002), University of Nottingham which he led until 2008. He is currently Head of the School of Molecular Medical Sciences, Faculty of Medicine and Health Sciences. Professor Williams' research interests have primarily focused on the molecular basis of bacterial pathogenicity. He and his research group are best known for their ground-breaking work on quorum sensing (QS), or global gene regulation through cell-to-cell communication, in bacteria of biotechnological, agricultural and medical importance. His team was the first to that discover QS is widespread in the bacterial kingdom controlling diverse behaviors’ from virulence and secondary metabolism to motility.

Professor Roger Beuerman
Singapore Eye Research Institute, School of Medicine, National University of Singapore, Singapore.

Roger Beuerman is currently Deputy and Senior Scientific Director of the Singapore Eye Research Institute, Adjunct Professor of Ophthalmology, Yong Loo Lin, School of Medicine at the National University of Singapore. His early work was in neurophysiology and he received the PhD degree in neuroscience from Florida State University. He has more than 25 years of experience in ophthalmology research working on the development of refractive surgical procedures, the clinical confocal microscope, proteomics and peptide based anti-microbials. He is well known internationally for work on ocular surface disease. Roger is the principal investigator of the SGH Stem Cell Research Group and worked on the use of ocular surface stem cells for clinical transplantation and on the development of new antimicrobial peptides, and ocular proteomics. He heads SCAMP, Singapore Consortium for the development of Antimicrobial Peptides, a network of scientists at SERI, BII, NTU and NUS that has successfully developed unique molecules with outstanding antimicrobial properties that are safe to the eye at high concentrations. He has edited two books in ophthalmology, the latest on dry eye. Overall, he has more than 200 publications sits on several editorial boards, such as Cornea and Ocular Surface and reviews grants for the Singapore General Hospital Foundation, the National Medical Research Council and the Biomedical Research Council.

Professor Dr Rahmah Mohamed
Deputy Vice Chancellor (Research and Innovation Affairs), Universiti Kebangsaan Malaysia.

Prof. Dr. Rahmah Mohamed is a Professor in molecular biology and genomics from the Faculty of Science and Technology (FST), UKM. Prof. Dr. Rahmah obtained her Bachelor degree in Biomolecular Science in 1980. She received her PhD in Biochemistry from Queensland University, Australia in 1986. Prof. Dr. Rahmah started her academic career in UKM in 1980 as a tutor at the Biochemical Unit, Faculty of Science. In 1986, she was appointed as a lecturer at the Biochemical Department, Faculty of Life Sciences and later on to Associate Professor in 1993. She later received her Professorship at the Centre for Bioscience and Biochemical Studies, FST in 2003.Previously, Prof. Dr. Rahmah had occupied a few important seats in UKM, such as the Head of the Centre of Gene Analysis and Technology, FST (1997-2002), Deputy Director of Interim Laboratory, National Institute of Genomics and Biomolecule (2002-2004), Deputy Director of Malaysia Genome Institute (2004-2006), Deputy Director of Centre of Research Management and Innovation (2006-2008) and Director of Centre of Research Management and Innovation (2008-15 January 2009). Prof. Dr. Rahmah is actively involved in research and has been awarded numerous international awards such as Research Co-operation Award Prime Minister’s Initiative from British Council 2008, Third World Academy of Science Young Scientist Award (TWAS/TWANSO) 1990, Cochran Fellowship-Programme in Biotechnology, USA, 1998, Malaysia Toray Science Foundation Grant Award, 1995, Third World Academy of Science Grant Award, 1992, FAO, United Nation Research Fellowship, 1992, Young Scientist Travel Fellowship, Federation of Asia and Oceania of Biochemistry and Molecular Biology, 1998. She is also active in writing and contributing to publications of academic journals. At the national level, Prof. Dr. Rahmah received Malaysia Young Scientist Award, MOSTE, 1990, UKM Excellent Service Award 1992 and 1994 and UKM Best Practice Award, 1998. Prof Dr Rahmah has been appointed as the new Deputy Vice Chancellor (Research and Innovation Affairs) of Universiti Kebangsaan Malaysia (UKM) commencing on 16 January 2009 to 15 January 2012.

Professor Dr Sazaly Abu Bakar
Department of Medical Microbiology, Faculty of Medicine, University of Malaya.

Sazaly Abu Bakar received a Ph.D. in Microbiology with specialization in virology at the University of Texas Medical Branch (UTMB), Galveston, Texas, U.S.A. He joined University Malaya (UM) as a lecturer in the Department of Medical Microbiology, Faculty of Medicine, in August 1992. He was promoted to Associate Professor in 1998 and as Professor in 2003. He is currently serving as the Head of Department of Medical Microbiology and also as the Director of the WHO Collaborating Center for Arbovirus Research and Reference (DF/DHF) and Tropical Infectious Diseases Research and Education Centre (TIDREC). Professor Sazaly has published many research papers in reputable journals in infectious diseases, filed numerous patents and supervised many highly successful postgraduate students. He served in many expert opinion panels and acted as research consultants to several privately funded projects. He regularly participates in activities associated with advancing research in Malaysia. Currently, he heads several research projects including the nationally funded Malaysia’s first large scale dengue virus genome sequencing project, a project to study the dynamics of dengue virus antigenic change in recurring dengue outbreaks. Professor Sazaly also maintains a strong research interest in survival mechanisms of microbes in extreme environment. He currently heads a project investigating the survival of microbes in microgravity using Acinetobacter as a model.

Associate Professor Dr Mariana Nor Shamsudin
Laboratory of Marine Science and Aquaculture Institute of Bioscience, Department of Medical Microbiology and Parasitology Faculty of Medicine and Health Sciences Universiti Putra Malaysia

Dr. Mariana Nor Shamsudin is an Associate Professor in the Department of Medical Microbiology and Parasitology, Faculty of Medicine Health Sciences, UPM and currently heads the Laboratory of Marine Science and Aquaculture in the Institute of Bioscience, one of the 9 research institutes in UPM. During her tertiary education in USA, she majored in Microbiology, specializing in bacteriology. In 1982 she joined UPM as a tutor after receiving her BS from Indiana University. After graduating with a MS degree from West Virginia University, she was appointed as a lecturer. Her PhD. dissertation from Auburn University in Alabama was research in vaccine development for aquatic organisms against Flexibacter columnaris, an aquatic pathogen. An effective and protective vaccine utilizing the lipopolysaccharide, a component of the cell wall was developed. Her research activity as part of her academic career include the application of molecular approaches for probing antimicrobial mechanisms of marine based products to combat multiple drug resistant pathogens, focusing on the pathogen MRSA among others. In her molecular epidemiology research, several methodological approaches are applied for use as surveillance tools and to characterize the local resistant pathogens, employing the MLST, spa and RAPD subtyping methodologies. Among substantial outputs of her research with her collaborators that have received research award recognitions are rapid molecular-based diagnostic kits for species specific identification and multiple drug resistant genes detection, immunomodulating feed with recombinants for health improvement of aquatic organisms and a prototyped status sanitizer known for its effectiveness and biosafety, employing marine based resources. To date special focus of her research is probing DNA genes encoding relevant survival function of the pathogen. The product has great potential to be proposed as alternate antimicrobial targets.

Professor Dr. Raha Abdul Rahim
Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia.

Raha Abdul Rahim received her BSc in Microbiology from Oklahoma State University and her MS in Microbiology (Microbial Genetics) from the University of Oklahoma, USA. She then pursued her PhD in Molecular Biology at the University of Strathclyde, Glasgow, UK. Raha is currently the Head of Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, University Putra Malaysia. She is the past- President and current Exco member to the Malaysian Society for Microbiology and an Exco member to the Asian Federation of Societies for Lactic Acid Bacteria. She is actively involved in research and has published many papers in Journals and Proceedings. Her research interest is in plasmid biology and developing tools for expression, display and secretion of heterologous proteins in Lactococcus lactis and other lactic acid bacteria.

Dr. Tee Kok Keng
Department of Medical Microbiology, Faculty of Medicine, University of Malaya.

Dr Tee received his BSc in Biomedical in 2003 and his Master of Medical Science in Molecular Epidemiology in 2005 from Univeristy of Malaya. He then pursued his PhD in Molecular Virology & Evolutionary Biology at the University of Malaya, Kuala Lumpur; and the National Institute of Infectious Diseases, Tokyo in 2009. Dr Tee’s major interests are in the molecular and evolutionary biology of RNA viruses including HIV, HCV, influenza virus, and EV71. Dr Tee has a strong background in investigating the spatio-temporal migration of human pathogens,evolutionary dynamics of recombinogenic viruses, and antiretroviral resistance.

Dr. Chan Kok Gan
Institute of Biological Sciences (Genetics & Molecular Biology), Faculty of Science, University of Malaya.

Dr Chan obtained double degrees in Microbiology and Laws simultaneously in 1996/97 (B.Sc (Hons) & LL.B (Hons)). His B.Sc (Hons) was sponsored by JPA Scholarship. In 2002, he obtained his double master degrees in Microbiology and Laws (M.Sc (Hons) & LL.M (Merit)) simultaneously. His M.Sc was sponsored by Postgraduate Scholarship from University of Malaya. In his LLM studies, Dr Chan specialized on intellectual property law, particularly biotechnology patents. Dr Chan obtained his Chartered Biologist membership in 2003. He is currently a senior lecturer in the Institute of Biological Sciences, UM. His current research interests are bacterial quorum sensing and quorum quenching in environmental bacteria.

2009 Developed by Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Malaysia